Skip to content
LLY Eli Lilly & Co NYSE
342.02 USD -1.72% -5.99
OPEN 348.01
PREV CLOSE 348.01
DAY RANGE 348.09 - 341.53
VOLUME 52173
AVG. VOLUME 2.5M
52 WEEK RANGE 384.44 - 231.87
Interactive Brokers Logotype

Buy LLY stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 330.7B
Enterprise value 345.6B
Trailing pe 52.332333
Forward pe 42.285545
Peg ratio 42.285545
Price to sales ttm 11.309067
Price to book mrq 31.108429
Enterprise to revenue 11.82
Enterprise to ebitda 33.295

Financials

Fiscal year ends 2021-12-31
Most recent quarter 2021-12-31
Profit margin 0.20634001
Operating margin 0.30052
Return on assets ttm 0.11484
Return on equity ttm 0.66592
Income statement
Revenue ttm 29.2B
Revenue per share ttm 32.397
Quarterly revenue growth 0.025
Gross profit ttm 21.3B
Ebitda 10.6B
Net income to common ttm 6B
Diluted eps ttm 6.65
Quarterly earnings growth yoy 0.308
Balance sheet
Total cash mrq 2.8B
Total cash per share mrq 2.972
Total debt mrq 16B
Total debt to equity mrq 157.797
Current ratio mrq 1.127
Book value per share mrq 11.187
Cash flow
Operating cash flow ttm 7.7B
Levered free cash flow ttm 5.9B

Stock statistics

Shares outstanding 1B
Float shares 0.9B
Avg 10 volume 2.7M
Avg 30 volume 2.6M
Shares short 4.9M
Short ratio 1.97
Short percent of shares outstanding 0.0062
Percent held by insiders 0.00151
Percent held by institutions 0.84858

Stock price summary

Fifty two week low 231.87
Fifty two week high 384.44
Fifty two week change 28.338
Beta 0.383676
Day 50 ma 360.7336
Day 200 ma 327.247

Dividends and splits

Forward annual dividend rate 4.52
Forward annual dividend yield 0.0128999995
Trailing annual dividend rate 3.79
Trailing annual dividend yield 0.010836931
5 year average dividend yield 1.78
Payout ratio 0.56990004
Dividend date 2023-03-10
Ex dividend date 2023-02-14
Last split factor 2-for-1 split
Last split date 1997-10-16

Eli Lilly (LLY) company profile

Eli Lilly and Company (NYSE:LLY) is a drug manufacturing company for humans and animals. The company engages in discovering, developing, manufacturing, and selling pharmaceutical products. Its products include Diabetes and other endocrinology products like Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. The company manufactures and sells its products through facilities in the United States, Puerto Rico, and eight other countries with production in about approximately 120 countries.

AD